You're signed outSign in or to get full access.
Integral Health Asset Management, LLC
Integral Health Asset Management, LLC is a New York-based, healthcare-focused alternative investment management firm founded in 2019 by Jay Rao, MD, JD. The firm is registered with the US SEC and is 100% employee owned. Integral Health specializes in investments across pharmaceutical, biotechnology, medical device, and healthcare service subsectors, aiming to deliver risk-adjusted absolute returns. The team combines top-tier finance, medical, and scientific expertise and serves institutional investors by supporting healthcare innovation and generating long-term value. The company employs approximately 10 professionals, most of whom are investors.
Investment Strategy
Integral Health Asset Management employs an absolute return strategy focused on the healthcare sector, investing across pharmaceutical, biotechnology, medical device, and healthcare service companies. The firm generates differentiated, actionable ideas based on scientific and financial research, aiming for consistent, idiosyncratic excess returns. Their strategy combines thematic, relative value, and event-driven trades, with strict portfolio guidelines and active risk management. The firm utilizes both top-down and bottom-up research, maintains a low net exposure within subsectors, and emphasizes capital preservation and minimized drawdowns. Investment decisions leverage a holistic industry view, identifying key drivers through structured, repeatable analysis with daily risk monitoring.
Latest 13F Filing Activity
Integral Health Asset Management, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 69 equity positions and 2 options positions with a total 13F market value of $1B. The fund increased holdings in Insmed Inc., Quest Diagnostics Inc., Regeneron Pharmaceuticals among other positions. Integral Health Asset Management, LLC reduced exposure to Gilead Sciences Inc., Ascendis Pharma A/s, Blueprint Medicines Corp. among others.
Top Holdings
Equity Positions (69)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
I INSM | INSMED INC | 14.74% | $161.0M | 1,600,000 | $38.34 | $100.64 | +$42.8M |
B BSX | BOSTON SCIENTIFIC CORP | 5.41% | $59.1M | 550,000 | $66.20 | $107.41 | -$6.5M |
T THC | TENET HEALTHCARE CORP | 4.43% | $48.4M | 275,000 | $90.95 | $176.00 | +$11.4M |
E EHC | ENCOMPASS HEALTH CORP | 3.59% | $39.2M | 320,000 | $81.42 | $122.63 | +$11.9M |
M MLYS | MINERALYS THERAPEUTICS INC | 3.34% | $36.5M | 2,700,000 | $14.35 | $13.53 | +$7.0K |
Options Positions (2)
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more